https://www.marketscreener.com/news/latest/Samsung-Bioepis-SB12-Soliris-Eculizumab-Biosimilar-Demonstrates-PK-PD-Bioequivalence-in-Phas-37290554/?utm_source=telegram&utm_medium=social&utm_campaign=share